Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Febuxostat Tablet Manufacturing

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This subcontract involves the manufacturing of Febuxostat tablets in 40MG and 80MG dosages to support prime contractors under Defense Logistics Agency Medical supply contracts. The scope of work encompasses the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, tablet compression using pharmaceutical grade equipment, and rigorous quality control testing within climate-controlled environments. All operations must maintain full compliance with FDA cGMP standards to ensure the delivery of bulk tablets that meet strict government specifications. This requirement falls under NAICS code 325412 and is managed by the Department of Defense. The response deadline for this opportunity is September 24, 2026.

General Info

Manufacturing 40MG and 80MG Febuxostat tablets for DoD under FDA cGMP standards.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2D2-26-R-0012.

The full solicitation package (9 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

PHARM MANUF/DISTR DIV - FSA

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures Febuxostat tablets in 40MG and 80MG dosages for prime contractors on DLA Medical supply contracts. Performs chemical synthesis of the active pharmaceutical ingredient (API), tablet compression, and quality control testing. Utilizes pharmaceutical grade tablet presses and climate-controlled manufacturing environments. Requires full compliance with FDA cGMP standards. Delivers bulk Febuxostat tablets meeting government specifications.

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS